Here are five things to know about ApiFix:
1. The system is approved in Europe and has the CE mark.
2. ApiFix is a non-fusion minimally invasive treatment for adolescent idiopathic scoliosis.
3. A clinical study shows there are many drawbacks to AIS surgery that don’t exist with the ApiFix procedure, including high levels of blood loss, transfusions and neurologic deficit.
4. The company is currently raising funds to fast-forward sales and market efforts to launch the device.
5. ApiFix is currently a commercial-stage company.
More articles on orthopedic devices:
Aesculap Implant Systems’ activL Artificial Disc receives FDA approval: 5 facts
Blue Belt Technologies’ STRIDE knee system used in 1k procedures
NuVasive CEO purchases stock worth $492k
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
